Neil Levine has been at Regeneron Pharmaceuticals, Inc. for the past three years and is currently Senior Director, Marketing – Ophthalmology, with responsibility for EYLEA® (aflibercept) Injection.
Neil spent the bulk of his career prior to joining Regeneron at Pfizer, Inc. serving in a range of roles within the finance and marketing organizations. He led the Viagra® (sildenafil citrate) Worldwide team and subsequent to the acquisition of Pharmacia, became Marketing Group Leader for Pfizer Ophthalmics and Endocrine Care. In this position, Neil had responsibility for Xalatan® (latanaprost ophthalmic solution), in addition to commercializing Macugen® (pegaptinib sodium) in conjunction with Eyetech Pharmaceuticals.
Immediately prior to joining Regeneron, Neil was Vice-President at Saatchi & Saatchi Healthcare Advertising.
Neil holds a BS from the University of Connecticut and an MBA from New York University.